Clinical Study of Individualized Vancomycin Dosing Based on Population PK Model

NCT06161870 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Severe Infection

Interventions

DRUG: individualized vancomycin dosing based on the population pharmacokinetics (PK) model
DRUG: empirical vancomycin dosing

Sponsor

Central South University